Training Fellowships

The Nanotechnology Characterization Laboratory (NCL) at NCI-Frederick conducts preclinical efficacy and toxicity testing of nanoparticles intended for cancer therapeutics and diagnostics. The NCL is a collaborating partnership between the National Cancer Institute, the U.S. Food and Drug Administration and the National Institute of Standards and Technology. As part of its analytical cascade, NCL characterizes nanoparticles' physical attributes, their in vitro biological properties, and their in vivo compatibility using animal models. The NCL assists the bio-nanotech community to identify structure activity relationships related to nanoparticle safety and efficacy. Research conducted at NCL, for instance, addresses the biological fate of nanomaterials, provides tools and methods for identifying mechanisms of toxicity, and informs environmental toxicologists about toxic mechanisms, target organs and systemic clearance processes.

Qualified postdoctoral applicants interested in NIH/NIST fellowships may select training positions at NIST focused on Nanotechnology Characterization Laboratory projects in physical characterization of nanomaterials.  This represents an opportunity to work in a world-class metrics laboratory on projects and platforms with significant impact in biomedicine. 

For more information on the Nanotechnology Characterization Laboratory, see http://ncl.cancer.gov.  For more information on the NCI Alliance for Nanotechnology in Cancer, see http://nano.cancer.gov. For more information on the NCI-FDA Research and Regulatory Fellowships, see http://www.cancer.gov/newscenter/pressreleases/IOTFQandA

NRC Research Associateship Program
Submission Deadline: May 1, 2007

NIH/NIST Joint Postdoctoral Program
Application Deadline: August 1, 2007